Verve Therapeutics
VERV
#6795
Rank
C$0.69 B
Marketcap
$8.26
Share price
11.24%
Change (1 day)
-56.38%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.28

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.56. In 2022 the company made an earnings per share (EPS) of -$4.20 a decrease over its 2021 EPS that were of -$3.64.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.281.76%
2022-$4.2015.54%
2021-$3.6461.32%
2020-$2.26